On March 13, 2026, the HS team conducted a comprehensive on-site visit and exchange at a key manufacturing partner’s production facility and quality control laboratory, reinforcing the company’s commitment to reliable supply and stringent quality standards for global pharmaceutical clients.

The inspection covered the partner’s state-of-the-art production workshops, advanced process pipelines, and fully equipped analytical laboratories, where the HS team evaluated operational workflows, safety protocols, and quality assurance systems in detail. Discussions with facility management and technical staff centered on production capacity, regulatory compliance, and quality control measures, ensuring alignment with international pharmaceutical standards and client requirements.

By engaging directly with the factory’s operations team, HS gained first-hand insights into the partner’s capabilities in API and intermediate manufacturing, as well as their robust quality management practices. This on-site verification not only solidifies trust in the supply chain but also lays the groundwork for enhanced collaboration on customized solutions and long-term business growth.

This factory inspection underscores HS’s proactive approach to supply chain management and quality assurance, further empowering the company to deliver reliable products and responsive service to international pharmaceutical markets. HS will continue to prioritize rigorous supplier evaluations and close partnerships to support sustainable success for its global clients.